![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
The International Business Communications conference on ‘Pulmonary Hypertension: New Understanding for Therapeutic Development’ was held in San Diego, CA, USA. Approximately 100 basic scientists and clinicians from academia and industry participated in this highly interactive two-day symposium on pulmonary hypertension (PHT). Topics discussed included current clinical therapies and novel therapeutic strategies, e.g., nitric oxide, phosphodiesterase (PDE) inhibition, prostacyclin synthase expression, endothelin receptor antagonism and elastase inhibition.